☰

Amy S. Duffield, Ph.D. - Publications

Affiliations: 
2005 Yale University, New Haven, CT 
Area:
Cell Biology
Tree Info Similar researchers PubMed Report error

49 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Xian RR, Xie Y, Haley LM, Yonescu R, Pallavajjala A, Pittaluga S, Jaffe ES, Duffield AS, McCall CM, Gheith SMF, Gocke CD. CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma. Blood Cancer Journal. 10: 69. PMID 32555149 DOI: 10.1038/S41408-020-0335-0  0.317
2020 Spivak JL, Merchant A, Williams DM, Rogers O, Zhao W, Duffield A, Resar LS, Moliterno AR, Zhao ZJ. Thrombopoietin is required for full phenotype expression in a JAK2V617F transgenic mouse model of polycythemia vera. Plos One. 15: e0232801. PMID 32479500 DOI: 10.1371/Journal.Pone.0232801  0.332
2019 Van Slambrouck C, Huh J, Suh C, Song JY, Menon MP, Sohani AR, Duffield AS, Goldberg RC, Dama P, Kiyotani K, Godfrey J, Fitzpatrick C, Kline J, Smith SM, Jaffe ES, et al. Diagnostic utility of STAT6 expression in classical Hodgkin lymphoma and related entities. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 31822802 DOI: 10.1038/S41379-019-0428-0  0.361
2019 Wu M, Li L, Hamaker M, Small D, Duffield AS. FLT3/ITD cooperates with Rac1 to modulate the sensitivity of leukemic cells to chemotherapeutic agents via regulation of DNA repair pathways. Haematologica. PMID 30975911 DOI: 10.3324/Haematol.2018.208843  0.339
2019 Zhu R, Li L, Nguyen B, Duffield AS, Small D. Gilteritinib and Venetoclax Synergize to Eliminate FLT3/ITD+ Leukemia Cells through BIM Blood. 134: 2564-2564. DOI: 10.1182/Blood-2019-131635  0.365
2019 Wu M, Li L, Small D, Duffield AS. DOCK2 Expression Affects Leukemogenesis and Disease Progression in a Murine Model of FLT3/ITD Acute Myeloid Leukemia Blood. 134: 2534-2534. DOI: 10.1182/Blood-2019-129157  0.308
2018 Annesley CE, Rabik C, Duffield AS, Rau RE, Magoon D, Li L, Huff V, Small D, Loeb DM, Brown P. Knock-in of the R394W mutation causes MDS and cooperates with to drive aggressive myeloid neoplasms in mice. Oncotarget. 9: 35313-35326. PMID 30450160 DOI: 10.18632/Oncotarget.26238  0.34
2018 Nagai K, Hou L, Li L, Nguyen B, Seale T, Shirley C, Ma H, Levis M, Ghiaur G, Duffield A, Small D. Combination of ATO with FLT3 TKIs eliminates FLT3/ITD+ leukemia cells through reduced expression of FLT3. Oncotarget. 9: 32885-32899. PMID 30250637 DOI: 10.18632/Oncotarget.25972  0.383
2018 Gong S, Crane GM, McCall CM, Xiao W, Ganapathi KA, Cuka N, Davies-Hill T, Xi L, Raffeld M, Pittaluga S, Duffield AS, Jaffe ES. Expanding the Spectrum of EBV-positive Marginal Zone Lymphomas: A Lesion Associated With Diverse Immunodeficiency Settings. The American Journal of Surgical Pathology. PMID 29957733 DOI: 10.1097/Pas.0000000000001113  0.318
2018 Duffield AS, Ascierto ML, Anders RA, Taube JM, McMiller TL, Engle EL, Meeker AK, Berger AE, Pardoll DM, Ambinder RF, Topalian SL. Abstract 4750: The immunosuppressive tumor microenvironment (TME) in nasopharyngeal carcinoma: implications for immunotherapy Cancer Research. 78: 4750-4750. DOI: 10.1158/1538-7445.Am2018-4750  0.32
2016 Wu M, Hamaker M, Li L, Small D, Duffield AS. DOCK2 interacts with FLT3 and modulates the survival of FLT3-expressing leukemia cells. Leukemia. PMID 27748370 DOI: 10.1038/Leu.2016.284  0.417
2016 Crane GM, Samols MA, Morsberger LA, Yonescu R, Thiess ML, Batista DA, Ning Y, Burns KH, Vuica-Ross M, Borowitz MJ, Gocke CD, Ambinder RF, Duffield AS. Tumor-Infiltrating Macrophages in Post-Transplant, Relapsed Classical Hodgkin Lymphoma Are Donor-Derived. Plos One. 11: e0163559. PMID 27685855 DOI: 10.1371/Journal.Pone.0163559  0.302
2016 Poitras JL, Heiser D, Li L, Nguyen B, Nagai K, Duffield AS, Gamper C, Small D. Dnmt3a deletion cooperates with the Flt3/ITD mutation to drive leukemogenesis in a murine model. Oncotarget. PMID 27636998 DOI: 10.18632/Oncotarget.11986  0.334
2016 Alikhan M, Song JY, Sohani AR, Moroch J, Plonquet A, Duffield AS, Borowitz MJ, Jiang L, Bueso-Ramos C, Inamdar K, Menon MP, Gurbuxani S, Chan E, Smith SM, Nicolae A, et al. Peripheral T-cell lymphomas of follicular helper T-cell type frequently display an aberrant CD3(-/dim)CD4(+) population by flow cytometry: an important clue to the diagnosis of a Hodgkin lymphoma mimic. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 27312067 DOI: 10.1038/Modpathol.2016.113  0.338
2016 Ma HS, Greenblatt SM, Shirley CM, Duffield AS, Bruner JK, Li L, Nguyen B, Jung E, Aplan PD, Ghiaur G, Jones RJ, Small D. All-trans retinoic acid synergizes with FLT3 inhibition to eliminate FLT3/ITD+ leukemia stem cells in vitro and in vivo. Blood. PMID 27103744 DOI: 10.1182/Blood-2015-05-646786  0.368
2016 Crane GM, Duffield AS. Hematolymphoid lesions of the sinonasal tract. Seminars in Diagnostic Pathology. 33: 71-80. PMID 26472692 DOI: 10.1053/J.Semdp.2015.09.008  0.311
2016 Nagai K, Hou L, Li L, Nguyen B, Shirley CM, Ma HS, Levis MJ, Duffield AS, Small D. Arsenic Trioxide Synergizes with FLT3 Tyrosine Kinase Inhibitors to Kill FLT3-ITD+ Leukemic Cells through Depressed Production and Degradation of FLT3 Protein Blood. 128: 1568-1568. DOI: 10.1182/Blood.V128.22.1568.1568  0.402
2015 Song JY, Venkataraman G, Fedoriw Y, Herrera AF, Siddiqi T, Alikhan MB, Kim YS, Murata-Collins J, Weisenburger DD, Liu X, Duffield AS. Burkitt leukemia limited to the bone marrow has a better prognosis than Burkitt lymphoma with bone marrow involvement in adults. Leukemia & Lymphoma. 1-6. PMID 26450341 DOI: 10.3109/10428194.2015.1085529  0.32
2015 Kern JB, Hii A, Kruse MJ, Szabo Z, Argani P, Hibbard MK, Gladstone DE, Meyer C, Zheng R, Borowitz MJ, Duffield AS. A leukemic presentation of alveolar rhabdomyosarcoma in a 52-year-old woman without an identifiable primary tumor. International Journal of Surgical Pathology. 23: 75-7. PMID 25305220 DOI: 10.1177/1066896914553666  0.323
2015 Ma HS, McCray ME, Shirley CM, Duffield AS, Bruner JK, Li L, Nguyen B, Greenblatt S, Jung E, Aplan PD, Jones RJ, Small D, Ghiaur G. FLT3 Inhibition and Retinoid Signaling Overcome Stromal Protection to Target FLT3/ITD-Expressing Leukemia Stem Cells in the Bone Marrow Microenvironment Blood. 126: 790-790. DOI: 10.1182/Blood.V126.23.790.790  0.365
2015 Spivak JL, Williams DM, Zhao ZJ, Rogers O, Duffield AS, Hankins WD, Moliterno AR. MPL SV, a Unique MPN MPL Splice Variant, Provokes a Fulminant Myeloid Leukemia in a JAK2 V617F Transgenic Mouse Model of Polycythemia Vera Blood. 126: 484-484. DOI: 10.1182/Blood.V126.23.484.484  0.338
2015 Wu M, Li L, Hamaker M, Small D, Duffield AS. DOCK2 Regulates DNA Damage Response and Modulates the Sensitivity to Chemotherapeutic Agents in FLT3/ITD Leukemic Cells Blood. 126: 3668-3668. DOI: 10.1182/Blood.V126.23.3668.3668  0.364
2015 Annesley CE, Duffield AS, Rau RE, McCarty G, Magoon D, Li L, Huff V, Small D, Loeb D, Brown P. A Wilms Tumor 1 (WT1) Mutation Causes Myelodysplastic Syndrome in a Knock-in Mouse Model, and a Mixed Myelodysplastic/Myeloproliferative Neoplam in Double Knock-in Mice with WT1 and FLT3/ITD Mutations Blood. 126: 312-312. DOI: 10.1182/Blood.V126.23.312.312  0.341
2015 Crane GM, Powell H, Kostadinov R, Burger PC, Ambinder RF, Swinnen LJ, Borowitz MJ, Duffield AS. Lymphoproliferative Disease Risk in Patients with Autoimmune Disease: Clustering of Primary CNS Lymphoma with Drug Regimen and Disease Process Blood. 126: 1490-1490. DOI: 10.1182/Blood.V126.23.1490.1490  0.319
2014 Crane GM, Xian RR, Burns KH, Borowitz MJ, Duffield AS, Taube JM. Primary effusion lymphoma presenting as a cutaneous intravascular lymphoma. Journal of Cutaneous Pathology. 41: 928-35. PMID 25355615 DOI: 10.1111/Cup.12405  0.34
2014 Ma HS, Nguyen B, Duffield AS, Li L, Galanis A, Williams AB, Brown PA, Levis MJ, Leahy DJ, Small D. FLT3 kinase inhibitor TTT-3002 overcomes both activating and drug resistance mutations in FLT3 in acute myeloid leukemia. Cancer Research. 74: 5206-17. PMID 25060518 DOI: 10.1158/0008-5472.Can-14-1028  0.322
2014 Crane GM, Ambinder RF, Shirley CM, Fishman EK, Kasamon YL, Taube JM, Borowitz MJ, Duffield AS. HHV-8-positive and EBV-positive intravascular lymphoma: an unusual presentation of extracavitary primary effusion lymphoma. The American Journal of Surgical Pathology. 38: 426-32. PMID 24525514 DOI: 10.1097/Pas.0000000000000128  0.36
2014 Ma H, Nguyen B, Li L, Greenblatt S, Williams A, Zhao M, Levis M, Rudek M, Duffield A, Small D. TTT-3002 is a novel FLT3 tyrosine kinase inhibitor with activity against FLT3-associated leukemias in vitro and in vivo. Blood. 123: 1525-34. PMID 24408321 DOI: 10.1182/Blood-2013-08-523035  0.364
2014 Rau R, Magoon D, Greenblatt S, Li L, Annesley C, Duffield AS, Huso D, McIntyre E, Clohessy JG, Reschke M, Pandolfi PP, Small D, Brown P. NPMc+ cooperates with Flt3/ITD mutations to cause acute leukemia recapitulating human disease. Experimental Hematology. 42: 101-13.e5. PMID 24184354 DOI: 10.1016/J.Exphem.2013.10.005  0.33
2014 Xian RR, Swinnen LJ, Lin M, Gocke CD, Duffield A. Presentation of late-relapse diffuse large B-cell lymphomas in extranodal sites may represent recurrences of the original disease. Journal of Clinical Oncology. 32. DOI: 10.1200/Jco.2014.32.15_Suppl.E19558  0.322
2014 Song JY, Venkataraman G, Fedoriw YD, Alikhan M, Kim Y, Weisenburger DD, Collins J, Liu X, Duffield AS. Burkitt Leukemia Involving Only the Bone Marrow Has a Better Prognosis Than Widespread Burkitt Lymphoma Involving the Bone Marrow in Adults Blood. 124: 4446-4446. DOI: 10.1182/Blood.V124.21.4446.4446  0.328
2014 Wu M, Hamaker M, Li L, Small D, Duffield AS. DOCK2 Interacts with FLT3 and Modulates the Survival of FLT3-Expressing Leukemia Cells Blood. 124: 3584-3584. DOI: 10.1182/Blood.V124.21.3584.3584  0.412
2014 Crane GM, Powell H, Kostadinov R, Ambinder RF, Swinnen LJ, Borowitz M, Duffield AS. A Rise in CNS Lymphoproliferative Disease Incidence Reveals a Protective Role of Calcineurin Inhibitors Blood. 124: 3020-3020. DOI: 10.1182/Blood.V124.21.3020.3020  0.307
2014 Xian RR, Crane GM, Haley LM, Gocke CD, Lin M, Pallavajjalla A, Borowitz MJ, Swinnen LJ, Duffield AS. Late-Relapse Diffuse Large B-Cell Lymphoma Frequently Represents Recurrence of the Original Disease, and Demonstrates Evidence of Superimposed Clonal Heterogeneity and Clonal Evolution Blood. 124: 2955-2955. DOI: 10.1182/Blood.V124.21.2955.2955  0.317
2013 Bailey E, Li L, Duffield AS, Ma HS, Huso DL, Small D. FLT3/D835Y mutation knock-in mice display less aggressive disease compared with FLT3/internal tandem duplication (ITD) mice. Proceedings of the National Academy of Sciences of the United States of America. 110: 21113-8. PMID 24255108 DOI: 10.1073/Pnas.1310559110  0.309
2013 Greenblatt SM, Jung E, Duffield AS, Li L, Ghiaur G, Jones RJ, Small D. All-Trans Retinoic Acid Synergizes With FLT3 Tyrosine Kinase Inhibition To Eliminate FLT3/ITD-Expressing Leukemia Cells Blood. 122: 3960-3960. DOI: 10.1182/Blood.V122.21.3960.3960  0.389
2012 McCall CM, Mudali S, Arceci RJ, Small D, Fuller S, Gocke CD, Vuica-Ross M, Burns KH, Borowitz MJ, Duffield AS. Flow cytometric findings in hemophagocytic lymphohistiocytosis. American Journal of Clinical Pathology. 137: 786-94. PMID 22523218 DOI: 10.1309/Ajcpp40Mexwyrlpn  0.312
2012 Duffield AS, Aoki J, Levis M, Cowan K, Gocke CD, Burns KH, Borowitz MJ, Vuica-Ross M. Clinical and pathologic features of secondary acute promyelocytic leukemia. American Journal of Clinical Pathology. 137: 395-402. PMID 22338051 DOI: 10.1309/Ajcpe0Mv0Ytwluue  0.324
2012 Greenblatt S, Li L, Slape C, Nguyen B, Novak R, Duffield A, Huso D, Desiderio S, Borowitz MJ, Aplan P, Small D. Knock-in of a FLT3/ITD mutation cooperates with a NUP98-HOXD13 fusion to generate acute myeloid leukemia in a mouse model. Blood. 119: 2883-94. PMID 22323452 DOI: 10.1182/Blood-2011-10-382283  0.344
2012 Emadi A, Sadrzadeh H, Patal P, Burns KH, Duffield A, Ballen KK, Amrein PC, Attar EC, Smith BD, Fathi AT. History of autoimmunity to predict clinical response to DNA methyltransferase inhibitors (DNMTI) in myelodysplastic syndromes (MDS), and MDS-derived acute myeloid leukemias (AML). Journal of Clinical Oncology. 30: 6629-6629. DOI: 10.1200/Jco.2012.30.15_Suppl.6629  0.33
2011 Stoll LM, Duffield AS, Johnson MW, Ali SZ. Acute myeloid leukemia with myelodysplasia-related changes with erythroid differentiation involving pleural fluid: a case report and brief cytopathologic review. Diagnostic Cytopathology. 39: 451-4. PMID 20954271 DOI: 10.1002/Dc.21470  0.338
2011 Greenblatt SM, Li L, Slape C, Novak RL, Duffield AS, Nguyen B, Huso D, Borowitz MJ, Aplan P, Small D. Knock-in of a FLT3 Internal Tandem Duplication Mutation Cooperates with a NUP98-HOXD13 Fusion to Generate Acute Myeloid Leukemia Blood. 118: 865-865. DOI: 10.1182/Blood.V118.21.865.865  0.361
2008 Duffield A, Caplan MJ, Muth TR. Protein trafficking in polarized cells. International Review of Cell and Molecular Biology. 270: 145-79. PMID 19081536 DOI: 10.1016/S1937-6448(08)01404-4  0.682
2008 Lin D, Kamsteeg EJ, Zhang Y, Jin Y, Sterling H, Yue P, Roos M, Duffield A, Spencer J, Caplan M, Wang WH. Expression of tetraspan protein CD63 activates protein-tyrosine kinase (PTK) and enhances the PTK-induced inhibition of ROMK channels. The Journal of Biological Chemistry. 283: 7674-81. PMID 18211905 DOI: 10.1074/Jbc.M705574200  0.52
2007 Kamsteeg EJ, Duffield AS, Konings IB, Spencer J, Pagel P, Deen PM, Caplan MJ. MAL decreases the internalization of the aquaporin-2 water channel. Proceedings of the National Academy of Sciences of the United States of America. 104: 16696-701. PMID 17940053 DOI: 10.1073/Pnas.0708023104  0.554
2007 Caplan MJ, Kamsteeg EJ, Duffield A. Tetraspan proteins: regulators of renal structure and function. Current Opinion in Nephrology and Hypertension. 16: 353-8. PMID 17565278 DOI: 10.1097/Mnh.0B013E328177B1Fa  0.533
2004 Duffield A, Fölsch H, Mellman I, Caplan MJ. Sorting of H,K-ATPase beta-subunit in MDCK and LLC-PK cells is independent of mu 1B adaptin expression. Traffic (Copenhagen, Denmark). 5: 449-61. PMID 15117319 DOI: 10.1111/J.1398-9219.2004.00192.X  0.525
2003 Duffield A, Kamsteeg EJ, Brown AN, Pagel P, Caplan MJ. The tetraspanin CD63 enhances the internalization of the H,K-ATPase beta-subunit. Proceedings of the National Academy of Sciences of the United States of America. 100: 15560-5. PMID 14660791 DOI: 10.1073/Pnas.2536699100  0.518
2003 Pagel P, Zatti A, Kimura T, Duffield A, Chauvet V, Rajendran V, Caplan MJ. Ion pump-interacting proteins: promising new partners. Annals of the New York Academy of Sciences. 986: 360-8. PMID 12763851 DOI: 10.1111/J.1749-6632.2003.Tb07215.X  0.506
Show low-probability matches.